Smartest Doc
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma Full Text
Clinical Cancer Research, 05/14/2012
Matsumura S et al. – The results suggest that methylation–mediated silencing of MZB1 expression leads to loss of its tumor–suppressive activity, which may be a factor in the hepatocarcinogenesis, and is a useful prognosticator in hepatocellular carcinoma.
